Product sourcing reference

KPV

KPV is a tripeptide fragment of alpha-MSH studied in inflammation models. Evidence is preclinical; review it as research material.

Reference variants

Add KPV to an order request

Quantities are individual vials (packs of 10). Orders need 100 vials and/or 20 spray bottles in total, mixed across items. Prices are reference estimates captured 2026-10-16; every request is pending eligibility and availability review. Per-unit figures are rounded to the cent from kit pricing, so a final quote may differ slightly.

10mgVial · confirm physical formCAS 67727-97-3

$18.12/vial$14.49/vial at 1,000+ vials of this item

Quantity of KPV 10mg in vials vials, packs of 10

Review your order request · Compare the full catalog

Confirm the exact substance

KPV (Lys-Pro-Val) is the C-terminal tripeptide of alpha-melanocyte-stimulating hormone. It is a different substance from full-length alpha-MSH analogues.

What the review will ask

Record the intended use and route. Anti-inflammatory findings in animal and cell models do not establish clinical benefit.

State the facility type, destination state and intended transaction. Do not send patient information.
Expect product- and lot-specific documentation to be requested before any material is accepted.
A listed price is a reference estimate. Availability, labeling, shipping and terms are confirmed in writing only after review.

Purchasing questions

Is KPV an approved drug ingredient?

No. There is no approved product containing KPV. Treat any request as requiring a full eligibility review.

Do not infer human safety from short sequence length

FDA reports that it has not identified human exposure data for KPV drug products by any route. A three-residue identity does not make that evidence gap disappear.

Documentation to request

Ask for the exact sequence and identity methods, and distinguish laboratory findings from any proposed human use.

Regulatory context: FDA: substance-specific safety concerns. Source reviewed 2026-10-16. This source does not verify the identity, testing or availability of our catalog references.

Related guidance: Evidence review before expanding a clinic menu. These references support a review, not a treatment recommendation or supply authorization.

Verify the current regulatory position

Use FDA human drug compounding guidance and applicable state requirements. This reference is not medical or legal advice and does not establish a lawful supply route.

Discuss sourcing requirements